European Psychiatry - Volume 33 - March 2016

123 / 812

24th European Congress of Psychiatry / European Psychiatry 33S (2016) S116–S348 S119
– the concentration of the CIK (circulating immunnokompleks) was
determined by precipitation with polyethylene glycol.
Patients of the 1st group was administered into the sevpram
10mg/day in combination with galavit (25mg daily); group 2 –
only the standard therapy (ST).
The results of research As a result of the treatment in the first
group showed an increase of 34.8%) the number of immunoglob-
ulin A, which however does not reach the level of healthy people
and reducing the number of circulating complexes by 13.8%, which
also indicates the normalization of this index. The first group – a
significant improvement of immunological parameters increase of
3 indicators (CD4, CD8, CD4/CD8) and a decrease in the CIK. Anal-
ysis of changes in indicators Hamilton Rating Scale for Depression,
also notes a reduction in the symptoms scores.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW09
Exercise addiction: Identification and
prevalence in physically active
adolescents and young eating
disordered patients
M. Lichtenstein ∗, R.K. Støving
1 Department of Psychology, University of Southern Denmark,
Odense, Denmark
2 Department of Clinical Research, Odense University Hospital,
Odense C, Denmark
∗ Corresponding author.
Introduction Exercise addiction is characterized by increasing
exercise amounts, withdrawal symptoms and lack of control. Eat-
ing disorders and exercise addiction often appear together, but only
eating disorders are recognized as diagnoses. However, exercise
addiction can exist independently from eating disorders and can
be as harmful as any other addictive behavior.
Objectives The Exercise Addiction Inventory (EAI) is useful to
identify exercise addiction symptoms in adults and prevalence
rates of 3–10% have been found. But a scale for adolescents does
not yet exist even though behavioral addictions seem to be more
prevalent among young people.
Aims To develop an instrument for identification of exercise
addiction in adolescents and to estimate the prevalence and nega-
tive consequences.
Methods We developed a Youth version of the EAI and screened
383 adolescents in sport settings and 69 patients from an eating
disorder department (age range 11–20 years).
Results The psychometric properties of the scale were good
(Cronbachs alpha 0.71). The prevalence of exercise addiction was
5.5% in adolescents in sport settings and 21.2% in eating disorder
patients. We found a positive linear relationship between EAI-score
and “highweekly exercise amounts” (r = 0.4,P = 0.00), “the tendency
to exercise in spite of injury” (r = 0.4, P = 0.00), “feelings of guilt
when not exercising” (r = 0.5, P= 0.00), “reduced sport performance
related to overtraining” (r = 0.2,P = 0.00), and “food dominating life”
(r = 0.2, P = 0.00).
Conclusions On basis of this study, we recommend the EAI-Y for
identification of exercise addiction in adolescents. Early identifi-
cation is important since it can prevent excessive and obsessive
exercise, injuries, reduced sport performance and eating disorder
pathology.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW10
PCP analogues in samples of
Barcelona from 2009 to 2015
M. Angelats ∗, L. Galindo , M. Grifell , Á. Palma , L. Martínez ,
L. Pujol , M. Ventura , I. Fornís , M. Torrens , M. Farré
1 Instituto de Neuropsiquiatría y Adicciones INAD, Parc de Salut Mar,
Psiquiatria, Barcelona, Spain
2 Energy Control, Asociación Bienestar y Desarrollo, Energy Control,
Barcelona, Spain
3 Instituto de Neuropsiquiatría y Adicciones INAD, Parc de Salut Mar,
Institut Hospital del Mar d’Investigacions Mèdiques IMIM, Parc de
Salut Mar, Universitat Autònoma de Barcelona, Psiquiatria,
Barcelona, Spain
4 Institut Hospital del Mar d’Investigacions Mèdiques IMIM, Parc de
Salut Mar, Universitat Autònoma de Barcelona, Servei de
Farmacologia Clínica, Hospital Universitari Germans Trias i Pujol,
IGTP, Farmacología, Barcelona, Spain
∗ Corresponding author.
Introduction Novel psychoactive substances (NPS) use is progres-
sively increasing year on year. The new analogues of phencyclidine
are frequently sold as legal dissociative anesthetic drug with hal-
lucinogenic and sedative effects, a legal alternative to ketamine,
acting as a high affinity and selective ligand of NMDA receptor
antagonists.
Objectives To describe the presence of 3- and 4-MeO-PCP in sam-
ples delivered to Energy Control from 2009 to 2015 in Spain.
Methods A total of 21,198 samples were analyzed from august
2009 to august 2015. Only those samples containing 4-MeO-PCP or
3-MeO-PCP were studied. They were analyzed by Energy Control,
a Spanish harm reduction NGO that offers the possibility of ana-
lyzing the substances that users report. Analysis was done by gas
chromatography–mass spectrometry.
Results All the samples resulted to be the acquired drug of the
consumer. Three samples were adulterated with substances as tra-
madol, cocaine, acetone among others.
Conclusions Three and 4-MeO-PCP consumption is not found to
be an emerging issue according to the results of our samples. Even
the potential harmful effects of these dissociative drugs, our indi-
rect indicator seems to show that consumption has not increased. A
more precise monitoring would make a better approach to the real
consumption and the impact of these substances in our society.
Disclosure of interest The authors declare that they have no com-
peting interest.
Acknowledgement Supported in part by grants of ISCIII-FEDER
(FIS PI11/0196), and The European Commission (Drug Prevention
and Information Program 2014-16, (JUST/2013/DPIP/AG/4823, EU-
MADNESS project). L. Galindo is a Rio Hortega fellowship (ISCIII;
CM14/00111).
EW11
Methylone consumption
characterized through samples
handled by users
L. Martínez Sadurní ∗, M. Grifell , L. Galindo , I. Ezquiaga ,
P. Quintana , M. Ventura , I. Fornís , Á. Palma , M. Angelats ,
E. Ribera , M. Torrens , M. Farré
1 Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar,
Psychiatry, Barcelona, Spain
2 Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, IMIM,
Universitat Autònoma de Barcelona, Psychiatry, Barcelona, Spain
3 Energy Control, Asociación Bienestar y Desarrollo, Primary care
medicine, Barcelona, Spain
4 Energy Control, Asociación Bienestar y Desarrollo, Energy Control,
Barcelona, Spain